TEVA Lowers Guidance For Second Qtr
Tweet Send to a Friend
Teva Pharmaceuticals (Nasdaq: TEVA) announced that the U.S. District Court for the District of Northern Illinois has granted Abbott's motion ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE